ClinicalTrials.Veeva

Menu

Parent Education and Choice About Newborn Screening and Bloodspot Retention

Utah System of Higher Education (USHE) logo

Utah System of Higher Education (USHE)

Status

Completed

Conditions

Neonatal Screening

Treatments

Behavioral: Viewing Residual Dried Blood Spot movie
Behavioral: Viewing Newborn Screening movie

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT02676245
R01HG006266 (U.S. NIH Grant/Contract)
IRB_00060088

Details and patient eligibility

About

To address the content, timing, efficacy, and impact of prenatal education about newborn screening generally and sample retention specifically.

Full description

It is widely recognized that new parents receive insufficient information about newborn screening (NBS) and little or no information regarding the retention of residual newborn screening samples. Our current research (R01 HD058854) clearly demonstrates that parents are supportive of NBS and the research use of residual specimens, but they want information before the child is born and want an informed choice regarding the retention and use of residual samples. Previous research has outlined the basic elements of what parents want to know about NBS generally. However, given that many states are adopting an "opt-out" approach for residual samples, it is unclear what basic information parents want to know to enable an informed choice about this practice. While it is recognized that retention and use of residual NBS samples is a valuable research resource, there are prevalent concerns in the NBS community that discussion of this will lead some parents to decline NBS altogether. Some authorities have suggested that discussions of NBS and residual sample retention be conducted separately to reduce the risk that parents will confuse the issues and decline NBS altogether.

To address this the project has the following specific aims:

Specific Aim 1) To determine what pregnant women, young mothers, and their partners want to know regarding the retention and use of residual bloodspot samples

Specific Aim 2) To create multimedia educational tools to be used in the prenatal care environment that will provide basic information about NBS and the core information determined through Specific Aim 1 about residual sample retention and use.

Specific Aim 3) To determine the impact of the prenatal education intervention on parental knowledge, attitudes, and decisions regarding NBS services and the retention and use of residual samples in diverse populations of English and Spanish speaking pregnant women.

Specific Aim 4) To examine the normative/ethical implications of the results of SA3 for the conduct of state NBS programs. Recommendations on the content and timing of parental NBS education will be developed.

Enrollment

664 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult (> 18 years) women
  • Uncomplicated pregnancy
  • English and Spanish speaking
  • Partners of pregnant women who have give birth.

Exclusion criteria

  • Women younger than 18 years
  • Complicated pregnancy

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

664 participants in 3 patient groups

Viewing NBS + DBS Educational Movies
Experimental group
Description:
Group A: pregnant women who will view the NBS and residual specimen movies and printed materials during one visit between 30 and 40 weeks gestation.
Treatment:
Behavioral: Viewing Residual Dried Blood Spot movie
Behavioral: Viewing Newborn Screening movie
Viewing NBS Educational Movie only
Experimental group
Description:
Group B: pregnant women who will view the NBS movie only and printed materials at one visit between 30 and 40 weeks. The movies will be presented on a tablet PC.
Treatment:
Behavioral: Viewing Newborn Screening movie
No Educational Interventions
No Intervention group
Description:
Control Group: pregnant women who will receive no experimental intervention during pregnancy or the postpartum period but will receive whatever information is routinely provided by their OB clinic and/or delivery center.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems